This test is most useful if any of these apply to you.
If you have year-round allergy symptoms that flare in dusty environments, around stored grains, or in barns and bakeries, a standard house dust mite test may not be enough. Acarus siro is a different creature, a storage mite that thrives in flour, hay, animal feed, and damp pantry corners, and your body can react to it independently of common dust mites.
This test looks for IgE antibodies (the immune protein behind classic allergic reactions) that specifically recognize Acarus siro proteins. A positive result tells you your immune system has been primed to react to this mite, which can show up as rhinitis, asthma, or worsening eczema.
Acarus siro IgE is an antibody your immune system makes after recognizing proteins from this storage mite as a threat. The antibody is produced by specialized white blood cells called B cells, and once it is made, it can attach to mast cells and basophils, the immune cells that release histamine and other chemicals during an allergic reaction.
The presence of this antibody means your immune system has been sensitized to Acarus siro. Sensitization is not the same as a clinical allergy. Some people have a detectable antibody without symptoms. But when sensitization lines up with real-world exposure and real-world symptoms, the IgE result is what links the symptom to the trigger.
Most allergy panels focus on the two common house dust mites, Dermatophagoides pteronyssinus and Dermatophagoides farinae. Storage mites like Acarus siro live in different environments and produce overlapping but distinct allergens. In one study of 196 urban adults, 14% had detectable IgE to at least one storage mite, including Acarus siro, even without occupational exposure to grain or flour.
Storage mite sensitization is especially common in people who work with grain or food. In a survey of 3,018 farmers on the Swedish island of Gotland, storage mite allergy was found in 6.2% of the whole farming population and in 37.8% of farmers with respiratory symptoms suggesting an IgE-driven allergy. Among Danish grain elevator workers, 15.9% were sensitized to storage mites and 6.4% had respiratory storage mite allergy.
Acarus siro IgE shows up most often in people with allergic rhinitis or asthma. In a study of 130 allergic rhinitis patients in Central China who were already known to react to house dust mite, 81.5% also had IgE to Acarus siro. The Acarus siro antibody levels in that group were typically lower than those for the two main house dust mites but still relevant to the clinical picture.
In a Northern European cohort of 1,180 people, storage mite allergy was about as common as house dust mite allergy and was independently associated with respiratory symptoms and asthma. In other words, storage mite sensitization carried its own risk signal, not just a shadow of dust mite allergy.
Among asthmatic children in Haikou, southern China, IgE to Acarus siro was part of a broader mite sensitization pattern. In that group, higher overall mite-specific IgE tracked with markers of active allergic airway inflammation, including blood eosinophil counts and exhaled nitric oxide, a breath test for airway inflammation.
Mite sensitization is also tied to eczema. In a study of 384 patients, IgE to specific dust mite proteins (including Der p 20) was linked to severe atopic dermatitis. The pattern is consistent: people whose immune systems are broadly reactive to mite allergens, including storage mites, are more likely to experience worse skin flares, alongside their nasal and breathing symptoms.
Reacting to multiple allergens at once tends to make symptoms worse. In a cohort of 500 allergic patients, 81% were polysensitized (reactive to multiple allergens), and polysensitization was associated with more severe asthma and rhinitis. If Acarus siro IgE turns up on your panel alongside house dust mite, pollen, or animal dander reactivity, that combination matters: each added sensitization tends to compound the symptom load.
One reason this result is easy to misinterpret is cross-reactivity. House dust mites and storage mites share some protein structures, so an antibody made against one can sometimes bind the other. In an early urban cohort, every person with storage mite IgE also had house dust mite IgE, and inhibition experiments showed considerable cross-reactivity between Dermatophagoides pteronyssinus and Acarus siro.
But cross-reactivity is not the whole story. In a separate study of 600 people in Ohio, binding patterns suggested limited cross-reactivity between Acarus siro and other storage mites, indicating that some people are independently sensitized to Acarus siro itself. The practical implication: a positive Acarus siro IgE may reflect a true, independent storage mite allergy, particularly if you have exposure to flour, grain, hay, or stored food, or it may be largely a cross-reaction with a dominant house dust mite allergy. Sorting that out usually requires looking at the whole panel and your exposure history together.
A single IgE reading is a snapshot. Specific IgE antibodies rise and fall over months and years based on exposure, treatment, and immune state. In a three-year study of allergen immunotherapy patients, dust mite IgE went up at first and then dropped significantly, and IgE to a non-target allergen (Artemisia pollen) also decreased modestly, showing that the immune system shifts over time in ways that one lab draw cannot capture.
The most useful approach is to establish a baseline now, retest in three to six months if you are starting an intervention like environmental control or immunotherapy, and then at least annually if symptoms continue. A trend tells you whether the immune system is calming down, holding steady, or escalating, which is far more actionable than any single number.
A positive Acarus siro IgE result should make you investigate, not panic. Ask three questions. First, do your symptoms match storage mite exposure? Rhinitis or asthma that worsens in barns, kitchens with old flour, basements, or while handling grain or pet food is a clue. Second, what does the rest of your allergy panel look like? If your house dust mite IgE is high and Acarus siro is roughly proportional, cross-reactivity may explain part of the signal. If Acarus siro stands alone or is disproportionately elevated, an independent storage mite allergy is more likely.
Third, who should you talk to? An allergist or immunologist is the right specialist for sorting out which sensitizations are clinically relevant, whether component-resolved testing (looking at individual mite proteins rather than the whole extract) would help, and whether allergen-specific immunotherapy makes sense. The goal is to confirm whether the antibody is driving real symptoms and to match the treatment to the specific trigger.
A few situations can make a single Acarus siro IgE reading harder to interpret:
Most allergy panels prioritize house dust mites, and many stop there. If you have storage mite exposure and a panel that did not include Acarus siro, you may have a real trigger flying under the radar. In one study of children, three common specific IgE assay platforms gave similar diagnostic performance for major aeroallergens like dust mite, but expanding the panel did not always improve clinical utility, meaning the test only adds value when the result actually changes what you do.
For Acarus siro specifically, the test is most useful when you have unexplained allergy symptoms, occupational or home exposure to grain or stored food, or a known dust mite allergy that is not fully explained by your standard panel. It is not a routine screening test for asymptomatic people.
Evidence-backed interventions that affect your Acarus Siro IgE level
Acarus Siro IgE is best interpreted alongside these tests.